• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APP/PS1转基因小鼠和野生型小鼠中,与年龄相关的刺激型谷氨酸释放及囊泡谷氨酸转运体的减少。

Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.

作者信息

Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, Goldsteins G, Iivonen H, Leguit N, Glennon J, Koistinaho J, Banerjee P, Tanila H

机构信息

A.I.Virtanen Institute for Molecular Sciences, University of Kuopio, Finland.

出版信息

J Neurochem. 2008 May;105(3):584-94. doi: 10.1111/j.1471-4159.2007.05147.x. Epub 2007 Nov 26.

DOI:10.1111/j.1471-4159.2007.05147.x
PMID:18042177
Abstract

We assessed baseline and KCl-stimulated glutamate release by using microdialysis in freely moving young adult (7 months) and middle-aged (17 months) transgenic mice carrying mutated human amyloid precursor protein and presenilin genes (APdE9 mice) and their wild-type littermates. In addition, we assessed the age-related development of amyloid pathology and spatial memory impaired in the water maze and changes in glutamate transporters. APdE9 mice showed gradual spatial memory impairment between 6 and 15 months of age. The stimulated glutamate release declined very robustly in 17-month-old APdE9 mice as compared to 7-month-old APdE9 mice. This age-dependent decrease in stimulated glutamate release was also evident in wild-type mice, although it was not as robust as in APdE9 mice. When compared to individual baselines, all aged wild-type mice showed 25% or greater increase in glutamate release upon KCl stimulation, but none of the aged APdE9 mice. There was an age-dependent decline in VGLUT1 levels, but not in the levels of VGLUT2, GLT-1 or synaptophysin. Astrocyte activation as measured by glial acidic fibrillary protein was increased in middle-aged APdE9 mice. Blunted pre-synaptic glutamate response may contribute to memory deficit in middle-aged APdE9 mice.

摘要

我们通过微透析技术,对携带突变型人类淀粉样前体蛋白和早老素基因的成年幼龄(7个月)和中年(17个月)转基因小鼠(APdE9小鼠)及其野生型同窝小鼠在自由活动状态下的基线和氯化钾刺激后的谷氨酸释放情况进行了评估。此外,我们还评估了淀粉样病理的年龄相关性发展、水迷宫中空间记忆的受损情况以及谷氨酸转运体的变化。APdE9小鼠在6至15个月大时表现出逐渐的空间记忆损害。与7个月大的APdE9小鼠相比,17个月大的APdE9小鼠中,刺激后的谷氨酸释放显著下降。尽管野生型小鼠中这种刺激后谷氨酸释放的年龄依赖性下降不如APdE9小鼠明显,但同样很显著。与各自的基线相比,所有老年野生型小鼠在氯化钾刺激后谷氨酸释放增加了25%或更多,但老年APdE9小鼠均未出现这种情况。VGLUT1水平呈现年龄依赖性下降,但VGLUT2、GLT-1或突触素的水平没有下降。通过胶质酸性纤维蛋白测量的星形胶质细胞活化在中年APdE9小鼠中增加。突触前谷氨酸反应减弱可能导致中年APdE9小鼠出现记忆缺陷。

相似文献

1
Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.APP/PS1转基因小鼠和野生型小鼠中,与年龄相关的刺激型谷氨酸释放及囊泡谷氨酸转运体的减少。
J Neurochem. 2008 May;105(3):584-94. doi: 10.1111/j.1471-4159.2007.05147.x. Epub 2007 Nov 26.
2
Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.在淀粉样前体蛋白(APP)和早老素1(PS1)双转基因小鼠中,海马β淀粉样蛋白42(Aβ42)水平与空间记忆缺陷相关。
Neurobiol Dis. 2002 Apr;9(3):339-47. doi: 10.1006/nbdi.2002.0481.
3
Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.淀粉样β蛋白与老年转基因 APP TgCRND8 小鼠多个记忆系统损伤。
Genes Brain Behav. 2009 Oct;8(7):676-84. doi: 10.1111/j.1601-183X.2009.00510.x. Epub 2009 May 26.
4
Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.阿尔茨海默病转基因小鼠模型中淀粉样蛋白负荷、铁负荷及磁共振弛豫时间的年龄相关性演变
Neurobiol Dis. 2006 Apr;22(1):199-208. doi: 10.1016/j.nbd.2005.10.013. Epub 2005 Dec 7.
5
Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.发作性记忆缺陷与 APPswe/PS1δE9 缺失型转基因小鼠 β-淀粉样蛋白病变模型 CA1 海马谷氨酸能突触传递和可塑性改变无关。
Neurobiol Aging. 2010 Jul;31(7):1173-87. doi: 10.1016/j.neurobiolaging.2008.08.005. Epub 2008 Sep 13.
6
Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice.APP + PS1转基因小鼠中LTP的正常诱导但加速衰减。
Neurobiol Dis. 2004 Mar;15(2):188-95. doi: 10.1016/j.nbd.2003.11.011.
7
Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.人淀粉样前体蛋白基因敲入/早老素-1转基因小鼠的中枢胆碱能功能
Neuroscience. 2004;125(4):1009-17. doi: 10.1016/j.neuroscience.2004.02.038.
8
Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.阿尔茨海默病 APP/PS1 转基因小鼠模型中溶酶体相关膜蛋白 1 的年龄依赖性增加和早期行为缺陷。
Neurosci Lett. 2010 Jan 22;469(2):273-7. doi: 10.1016/j.neulet.2009.12.015. Epub 2009 Dec 16.
9
Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.双转基因PS1+APP小鼠中阿尔茨海默病样病理发展的时间进程。
Exp Neurol. 2002 Feb;173(2):183-95. doi: 10.1006/exnr.2001.7754.
10
A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.一种具有细胞外β淀粉样蛋白沉积的阿尔茨海默病转基因大鼠模型。
Neurobiol Aging. 2009 Jul;30(7):1078-90. doi: 10.1016/j.neurobiolaging.2007.10.006. Epub 2007 Nov 28.

引用本文的文献

1
Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer's disease in a mouse model.通过靶向低密度脂蛋白受体相关蛋白1(LRP1)的纳米颗粒进行辛伐他汀的内皮递送可改善阿尔茨海默病小鼠模型的发病机制。
Alzheimers Res Ther. 2025 Aug 20;17(1):193. doi: 10.1186/s13195-025-01840-5.
2
Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity and Alzheimer's disease models.一种治疗性人源化促卵泡激素阻断抗体在肥胖和阿尔茨海默病模型中的疗效与安全性。
J Clin Invest. 2025 Jul 15;135(17). doi: 10.1172/JCI182702. eCollection 2025 Sep 2.
3
Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis.
连接蛋白43半通道阻断可使小胶质细胞具有神经保护作用,并减轻淀粉样变性小鼠模型中的认知缺陷。
Nat Commun. 2025 Jul 1;16(1):5621. doi: 10.1038/s41467-025-60746-w.
4
Photobiomodulation mitigates blood-brain barrier disruption in APP/PS1 mouse model of Alzheimer's disease by activating the AMPK pathway.光生物调节通过激活AMPK途径减轻阿尔茨海默病APP/PS1小鼠模型中的血脑屏障破坏。
Alzheimers Res Ther. 2025 Jun 23;17(1):141. doi: 10.1186/s13195-025-01787-7.
5
Identification and validation of pyroptosis-related genes in Alzheimer's disease based on multi-transcriptome and machine learning.基于多转录组和机器学习的阿尔茨海默病中焦亡相关基因的鉴定与验证
Front Aging Neurosci. 2025 May 14;17:1568337. doi: 10.3389/fnagi.2025.1568337. eCollection 2025.
6
Reactive Astrocytes with Reduced Function of Glutamate Transporters in the Knock-in Mice.谷氨酸转运体功能降低的基因敲入小鼠中的反应性星形胶质细胞
ACS Chem Neurosci. 2025 Jun 4;16(11):2035-2047. doi: 10.1021/acschemneuro.4c00714. Epub 2025 May 27.
7
Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP/PS1 mousmodel of Alzheimer's disease.光生物调节可调节线粒体能量代谢,并改善阿尔茨海默病APP/PS1小鼠模型中的神经损伤。
Alzheimers Res Ther. 2025 Apr 5;17(1):72. doi: 10.1186/s13195-025-01714-w.
8
HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological Disorders.组蛋白去乙酰化酶3作为阿尔茨海默病和其他神经疾病的新兴治疗靶点。
Mol Neurobiol. 2025 Mar 24. doi: 10.1007/s12035-025-04866-w.
9
Age-related differences in resting glutamate levels and glutamate uptake in the hippocampus and frontal cortex of C57BL/6 mice.C57BL/6小鼠海马体和额叶皮质中静息谷氨酸水平及谷氨酸摄取的年龄相关差异。
Neurobiol Aging. 2025 Jun;150:146-156. doi: 10.1016/j.neurobiolaging.2025.03.008. Epub 2025 Mar 18.
10
Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease.在阿尔茨海默病小鼠模型中,长期给予氟乙基去甲美金刚(FENM)的神经保护作用。
Alzheimers Res Ther. 2025 Jan 6;17(1):7. doi: 10.1186/s13195-024-01648-9.